Related Experiment Video
Updated: May 12, 2026

Analyzing Oxygen Consumption Rate in Primary Cultured Mouse Neonatal Cardiomyocytes Using an Extracellular Flux Analyzer
Published on: February 13, 2019
A mutation in the mitochondrial fission gene Dnm1l leads to cardiomyopathy
Houman Ashrafian1, Louise Docherty, Vincenzo Leo
1Department of Cardiovascular Medicine and Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Abstract:
Mutations in a number of genes have been linked to inherited dilated cardiomyopathy (DCM). However, such mutations account for only a small proportion of the clinical cases emphasising the need for alternative discovery approaches to uncovering novel pathogenic mutations in hitherto unidentified pathways. Accordingly, as part of a large-scale N-ethyl-N-nitrosourea mutagenesis screen, we identified a mouse mutant, Python, which develops DCM. We demonstrate that the Python phenotype is attributable to a dominant fully penetrant mutation in the dynamin-1-like (Dnm1l) gene, which has been shown to be critical for mitochondrial fission. The C452F mutation is in a highly conserved region of the M domain of Dnm1l that alters protein interactions in a yeast two-hybrid system, suggesting that the mutation might alter intramolecular interactions within the Dnm1l monomer. Heterozygous Python fibroblasts exhibit abnormal mitochondria and peroxisomes. Homozygosity for the mutation results in the death of embryos midway though gestation. Heterozygous Python hearts show reduced levels of mitochondria enzyme complexes and suffer from cardiac ATP depletion. The resulting energy deficiency may contribute to cardiomyopathy. This is the first demonstration that a defect in a gene involved in mitochondrial remodelling can result in cardiomyopathy, showing that the function of this gene is needed for the maintenance of normal cellular function in a relatively tissue-specific manner. This disease model attests to the importance of mitochondrial remodelling in the heart; similar defects might underlie human heart muscle disease.
Insights
A novel mutation in the dynamin-1-like (Dnm1l) gene causes dilated cardiomyopathy (DCM) in mice by disrupting mitochondrial fission. This study highlights the role of mitochondrial remodeling in heart muscle disease.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- Inherited dilated cardiomyopathy (DCM) is linked to gene mutations, but many cases remain unexplained.
- Novel discovery approaches are needed to identify new genetic causes and pathways involved in DCM.
Purpose of the Study:
- To identify novel genetic causes of DCM using a large-scale mutagenesis screen.
- To investigate the role of mitochondrial dynamics in the pathogenesis of DCM.
Main Methods:
- A mouse mutagenesis screen using N-ethyl-N-nitrosourea identified a DCM mutant, 'Python'.
- Genetic analysis identified a mutation in the dynamin-1-like (Dnm1l) gene.
- Yeast two-hybrid system and fibroblast analysis were used to study Dnm1l protein interactions and cellular phenotypes.
Main Results:
- The Python mouse mutant exhibits DCM due to a dominant C452F mutation in Dnm1l, a gene critical for mitochondrial fission.
- Heterozygous Python fibroblasts show abnormal mitochondria and peroxisomes.
- Heterozygous hearts display reduced mitochondrial enzyme complexes and ATP depletion, suggesting energy deficiency contributes to cardiomyopathy.
- Homozygosity for the Dnm1l mutation is embryonic lethal.
Conclusions:
- This study demonstrates that defects in mitochondrial remodeling, specifically Dnm1l function, can cause cardiomyopathy.
- The Python mouse model underscores the importance of mitochondrial dynamics in cardiac function and provides a model for studying heart muscle disease.
- This research suggests that impaired mitochondrial remodeling may underlie some human heart muscle diseases.
Related Concept Videos
Animal Mitochondrial Genetics
ATP Synthase: Mechanism
Satellite Stem Cells and Muscular Dystrophy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

